HOME >> BIOLOGY >> NEWS
AACR and The V Foundation form Translational Cancer Research Alliance

A new alliance to promote and reward outstanding cancer research that links basic scientists with clinicians has been established between the American Association for Cancer Research and The V Foundation for Cancer Research.

The V Foundation-AACR Grants in Translational Cancer Research support the development of novel approaches to the prevention, diagnosis and treatment of cancer. Translational research is a two-way bridge that conveys new ideas and discoveries between the laboratory and the clinic. In this manner, advances in such areas as molecular genetics, regulatory proteins and cellular signaling can be applied to new diagnostic technologies, targeted treatments and prevention strategies to help the cancer patient.

Grant winners will be announced in September 2004, with funding to begin in October.

"These grants will make a significant contribution toward the prevention and cure of cancer by bringing together talented basic and clinical scientists throughout the United States," said Margaret Foti, Ph.D., M.D. (h.c.), Chief Executive Officer of the AACR, the world's oldest and largest scientific organization dedicated to cancer and cancer-related biomedical research. AACR provides a vital link between translational scientists and clinicians, and fosters important connections between these two research groups.

"This unique collaboration between AACR and The V Foundation will benefit cancer patients around the world," added Dr. Foti. "These new grants represent an exciting new opportunity to capitalize on our advances in basic cancer research and translate them into a benefit for cancer patients."

In welcoming this new partnership, Nick Valvano, Chief Executive Officer of The V Foundation said, "We are excited and honored to form this alliance. Since 1993, one of our goals has been to fund the best and brightest research scientists. This collaboration ensures that we will be able to continue to achieve that
'"/>

Contact: Warren Froelich
froelich@aacr.org
215-440-9300
American Association for Cancer Research
18-Feb-2004


Page: 1 2

Related biology news :

1. Brown ecologist garners major National Science Foundation grant
2. APS Foundation names student travel award recipients
3. Institute for OneWorld Health receives Gates Foundation grant
4. National Parkinson Foundation designates UNC as Center of Excellence
5. National Cancer Gene Therapy Foundation gives $4.0 million in research grants
6. Leslie Ann Schiff wins 2004 Carski Foundation Award
7. Grant from GE Foundation to University of Houston to strengthen math, tech pipeline
8. National Foundation For Cancer Research names UCSDs Webster Cavenee NFCR Fellow
9. Green Foundation, Trust gives $12.8 million for UT Southwestern comprehensive research center
10. Gates Foundation commits $82.9 million to develop new tuberculosis vaccines
11. Mind Science Foundation announces Rare Consciousness Research Awards

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/11/2019)... ... June 12, 2019 , ... With ... Abveris plans to leverage the Geneious Biologics platform as a premium hub for ... Officer at Abveris, says: “The Geneious team has done an excellent job accommodating ...
(Date:6/6/2019)... ... June 05, 2019 , ... Ziegler, a ... advisor to Pathologists Bio-Medical Laboratories (PBM) on its recent acquisition by PathGroup. ... that provides services to more than one dozen hospitals and surgery centers in ...
(Date:6/4/2019)... ... , ... Most preclinical EEG visualization platforms offer tools intended ... on variations of amplitude, frequency or spike train detection. In the clinic, however, ... complexity and variability of the signal, and automation tools are used only in ...
Breaking Biology News(10 mins):
(Date:7/2/2019)... Calif. (PRWEB) , ... July 02, 2019 , ... Leading ... documentary entitled Animal Pharm: Where Beasts Meet Biotech. The film focuses on regenerative ... wild animals. Animal Pharm was recently included in the Brentwood and ...
(Date:6/18/2019)... (PRWEB) , ... June 18, 2019 , ... Personalized ... Investigational New Drug (IND) application to the FDA for use of a person’s own ... as a treatment of osteoarthritis in the knee. This IND is the first ...
(Date:6/11/2019)... ... 2019 , ... Advancements with Ted Danson will focus on ... 4Q/2019. Check your local listings for more information. , Advancements will explore Bio-ITech ... facilitates laboratories to improve efficiency and quality of research by providing comprehensive and ...
(Date:6/11/2019)... ... June 11, 2019 , ... Veterinary Regenerative ... Inc. (PSC) , has announced that their GMP facility for cell production is ... for manufacturing. This is an important milestone for VetStem as it expands ...
Breaking Biology Technology:
Cached News: